Avadel Pharmaceuticals
AVDL
#4577
Rank
$2.09 B
Marketcap
$21.31
Share price
-0.05%
Change (1 day)
109.95%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2025 (TTM): -$3.26 Million USD

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are $0.24 Billion USD. In 2024 the company made an earning of -$49.08 Million USD, an increase over its 2023 earnings that were of -$0.17 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$3.26 Million-93.37%
2024 -$49.08 Million-69.47%
2023 -$0.17 Billion44.27%
2022 -$0.12 Billion19.64%
2021 -$93.15 Million1732.84%
2020 -$5.09 Million-86.83%
2019 -$38.59 Million-65.92%
2018 -$0.12 Billion-222.16%
2017 $92.66 M-1053.49%
2016 -$9.72 Million-112.59%
2015 $77.19 M-185.94%
2014 -$89.83 Million66.04%
2013 -$54.1 Million582.16%
2012 -$7.93 Million-7.6%
2011 -$8.59 Million-2.1%
2010 -$8.77 Million32.52%
2009 -$6.62 Million-64.36%
2008 -$18.57 Million-52.93%
2007 -$39.44 Million5.66%
2006 -$37.32 Million17.86%
2005 -$31.67 Million-375.09%
2004 $11.51 M-406.44%
2003 -$3.76 Million-145.2%
2002 $8.3 M-363.36%
2001 -$3.16 Million-80.62%
2000 -$16.29 Million132.68%
1999 -$7 Million-50.34%
1998 -$14.1 Million54.85%
1997 -$9.1 Million-28.35%
1996 -$12.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-$18.16 Million 457.62%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-$0.16 Billion 4,798.00%๐Ÿ‡บ๐Ÿ‡ธ USA